261 related articles for article (PubMed ID: 18948811)
21. Limited survival in the treatment of carcinomatosis from rectal cancer.
Gomes da Silva R; Cabanas J; Sugarbaker PH
Dis Colon Rectum; 2005 Dec; 48(12):2258-63. PubMed ID: 16228825
[TBL] [Abstract][Full Text] [Related]
22. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
[TBL] [Abstract][Full Text] [Related]
23. [Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute].
Zoetmulder FA; van der Vange N; Witkamp AJ; Kaag MM; Boot H; Beijnen JH
Ned Tijdschr Geneeskd; 1999 Sep; 143(37):1863-8. PubMed ID: 10526600
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
Jacks SP; Hundley JC; Shen P; Russell GB; Levine EA
J Surg Oncol; 2005 Aug; 91(2):112-7; discussion 118-9. PubMed ID: 16028284
[TBL] [Abstract][Full Text] [Related]
25. [Treatment results of peritoneal dissemination from gastric cancer by neoadjuvant intraperitoneal-systemic chemotherapy].
Yonemura Y; Kawamura T; Bando E; Takahashi S; Sawa T; Yoshimitsu Y; Obata T; Endo Y; Sasaki T; Sugarbaker PH
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1723-6. PubMed ID: 15553695
[TBL] [Abstract][Full Text] [Related]
26. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.
González-Moreno S; Brun E; Sugarbaker PH
Ann Surg Oncol; 2005 Jan; 12(1):72-80. PubMed ID: 15827781
[TBL] [Abstract][Full Text] [Related]
27. The management of peritoneal surface malignancy of colorectal cancer origin.
Tentes AA
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s39-42. PubMed ID: 15655638
[TBL] [Abstract][Full Text] [Related]
28. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR
J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042
[TBL] [Abstract][Full Text] [Related]
29. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.
Smeenk RM; Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.
Elias DM; Ouellet JF
Surg Oncol Clin N Am; 2001 Oct; 10(4):915-33, xi. PubMed ID: 11641098
[TBL] [Abstract][Full Text] [Related]
31. Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer.
Carmignani CP; Sugarbaker PH
Eur J Surg Oncol; 2004 Oct; 30(8):864-8. PubMed ID: 15336733
[TBL] [Abstract][Full Text] [Related]
32. Results of treatment of 33 patients with peritoneal mesothelioma.
Sebbag G; Yan H; Shmookler BM; Chang D; Sugarbaker PH
Br J Surg; 2000 Nov; 87(11):1587-93. PubMed ID: 11091251
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.
Shen P; Hawksworth J; Lovato J; Loggie BW; Geisinger KR; Fleming RA; Levine EA
Ann Surg Oncol; 2004 Feb; 11(2):178-86. PubMed ID: 14761921
[TBL] [Abstract][Full Text] [Related]
34. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Schmidt U; Dahlke MH; Klempnauer J; Schlitt HJ; Piso P
Eur J Surg Oncol; 2005 Feb; 31(1):53-8. PubMed ID: 15642426
[TBL] [Abstract][Full Text] [Related]
35. The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy.
Pomel C; Appleyard TL; Gouy S; Rouzier R; Elias D
Eur J Surg Oncol; 2005 Jun; 31(5):540-3. PubMed ID: 15922890
[TBL] [Abstract][Full Text] [Related]
36. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.
Ahmad SA; Kim J; Sussman JJ; Soldano DA; Pennington LJ; James LE; Lowy AM
Ann Surg Oncol; 2004 Apr; 11(4):387-92. PubMed ID: 15070598
[TBL] [Abstract][Full Text] [Related]
37. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.
Nonaka D; Kusamura S; Baratti D; Casali P; Cabras AD; Younan R; Rosai J; Deraco M
Cancer; 2005 Nov; 104(10):2181-8. PubMed ID: 16206294
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management.
Jacquet P; Vidal-Jove J; Zhu B; Sugarbaker P
Acta Chir Belg; 1994; 94(4):191-7. PubMed ID: 8053288
[TBL] [Abstract][Full Text] [Related]
39. Abdominal carcinomatosis in women with a history of breast cancer.
Garg R; Zahurak ML; Trimble EL; Armstrong DK; Bristow RE
Gynecol Oncol; 2005 Oct; 99(1):65-70. PubMed ID: 15979132
[TBL] [Abstract][Full Text] [Related]
40. Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin.
Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2004 Apr; 30(3):280-5. PubMed ID: 15028309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
